subject: Cleveland Biolabs, Inc. (cbli) - Financial And Strategic Analysis Review - Aarkstore Enterprise [print this page] Aarkstore announce a new report "Cleveland BioLabs, Inc. (CBLI) - Financial and Strategic Analysis Review" through its vast collection of market research report.
Cleveland BioLabs, Inc. (Cleveland) is a publicly held research based biotechnology company. It is engaged in the development of innovative therapeutics for the prevention and treatment of cancer. The company currently develops products from two primary families of compounds; protectans and curaxins. It develops protectans CBLB502 as a drug candidate against acute radiation syndrome. The company also develops curaxins CBLC102 as anti cancer agent for prostate cancer.
Jan 28, 2010: EPO Grants Patent To Cleveland For Radiation Protection Drug
Jan 06, 2010: USPTO Issues Patent To Cleveland CBLB502
Dec 30, 2009: Cleveland BioLabs, Bioprocess Capital Ventures Form Joint Venture
Nov 23, 2009: Cleveland Initiates Enrollment For Second Safety Study Of ARS Drug
This comprehensive SWOT profile of Cleveland BioLabs, Inc. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Cleveland BioLabs, Inc., including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).
The profile contains critical company information including*,
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
